Skip to main content

Day: September 4, 2020

OMNIQ Corp. Announces Deployment of AI-based SeeDOT™️ Systems for Southern U.S. State

State benefits from accurate and efficient monitoring of commercial vehicles at weigh stations using OMNIQ’s Neural Network-based algorithmThree of 14 SeeDOT™️ systems ordered have now been installedSALT LAKE CITY, Sept. 04, 2020 (GLOBE NEWSWIRE) — OMNIQ Corp. (OTCQB: OMQS) (“OMNIQ” or “the Company”), a provider of Supply Chain and Artificial Intelligence (AI)-based solutions, today announced that its image-processing division HTS has begun deploying SeeDOT™️ systems, OMNIQ’s solution for automating vehicle monitoring at weigh and safety stations, for an order received from a Southern U.S. state.  The SeeDOT™️ systems, which will replace old equipment, are powered by OMNIQ’s proprietary AI-based, deep-learning neural network algorithm (“SeeNN™️”).  Three of 14 SeeDOT™️ systems comprising the order have now been successfully completed,...

Continue reading

Orkuveita Reykjavíkur: Stækkun verðbréfalána til viðskiptavaka

Orkuveita Reykjavíkur (OR) hefur í gildi samninga um viðskiptavakt með skuldabréf útgefin í skuldabréfaflokkum OR; OR180255 GB, OR020934 GB og OR090546 við Arion Banka hf., Íslandsbanka hf., Landsbankann hf. og Kviku Banka hf., sbr. fyrri fréttatilkynningar um viðskiptavakt. OR hefur nú gert viðauka við téða samninga þess efnis að hækka heimildir viðskiptavaka til tímabundinna verðbréfalána úr 60 m.kr. í 120 m.kr. Samningsbreytingin tekur gildi þann 4. september 2020. Til að standa við framangreindar samningsskuldbindingar um verðbréfalán í tengslum við áðurnefnda viðskiptavakt mun OR stækka hvern flokk um 80 m.kr. að nafnvirði.Heildarstærð flokkanna eftir stækkun vegna verðbréfalána er eftirfarandi: OR180255 GB, 20.131.000.000 kr. að nafnvirði, OR020934 GB, 5.295.000.000 kr. að nafnvirði og OR090546, 20.021.243.199 kr. að nafnvirði.

Continue reading

Reykjavik Energy: Changes to market making agreement

Reykjavik Energy (OR) has valid market making agreements with Arion Bank, Islandsbanki, Landsbanki and Kvika Bank in OR’s bond series; OR180255 GB, OR020934 GB and OR090546, see previous news releases regarding market making agreement.OR has made an addendum to this agreement which entails that the amount of bonds a market maker can temporarily borrow is increased from a nominal amount of ISK 60m to a nominal amount of ISK 120m. This change is effective from September 4th 2020. To meet its lending obligations under the market making agreement, OR will issue additional bonds in each series for a nominal value of ISK 80m.Total outstanding nominal value of the series is as follows: OR180255 GB nominal value of ISK 20.131.000.000, OR020934 GB nominal value of ISK 5.295.000.000 and OR090546 nominal value of ISK 20.021.243.199.

Continue reading

Auction result of T-bonds – RIKS 33 0321

Series  RIKS 33 0321Settlement Date  09/09/2020Total Amount Allocated (MM)  2,522All Bids Awarded At (Price / Yield)  133.880 / 0.250Total Number of Bids Received  48Total Amount of All Bids Received (MM)  5,385Total Number of Successful Bids  19Number of Bids Allocated in Full  19Lowest Price / Highest Yield Allocated  133.880 / 0.250Highest Price / Lowest Yield Allocated  135.500 / 0.140Lowest Price / Highest Yield Allocated in Full  133.880 / 0.250Weighted Average of Successful Bids (Price/Yield)  134.515 / 0.206Best Bid (Price / Yield)  135.500 / 0.140Worst Bid (Price / Yield)  129.582 / 0.550Weighted Average of All Bids Received (Price / Yield)  133.539 / 0.273Percentage Partial Allocation (Approximate)  100.00 %Bid to Cover Ratio  2.14

Continue reading

Niðurstaða í útboði ríkisbréfa – RIKS 33 0321

Flokkur  RIKS 33 0321Greiðslu-og uppgjörsdagur  09.09.2020Samþykkt tilboð að nafnverði (m.kr.)  2.522Samþykkt (verð / ávöxtunarkrafa)  133,880 / 0,250Fjöldi innsendra tilboða  48Upphæð móttekinna tilboða að nafnverði (m.kr.)  5.385Fjöldi samþykktra tilboða  19Fjöldi samþykktra tilboða úthlutað að fullu  19Lægsta úthlutaða verð / Hæsta úthlutaða ávöxtunarkrafa  133,880 / 0,250Hæsta úthlutaða verð / Lægsta úthlutaða ávöxtunarkrafa  135,500 / 0,140Lægsta verð / Hæsta ávöxtunarkrafa úthlutað að fullu  133,880 / 0,250Vegið meðaltal samþykktra tilboða (verð / ávöxtunarkrafa)  134,515 / 0,206Besta tilboð (verð / ávöxtunarkrafa)  135,500 / 0,140Versta tilboð (verð / ávöxtunarkrafa)  129,582 / 0,550Vegið meðaltal innsendra tilboða (verð / ávöxtunarkrafa)  133,539 / 0,273Hlutfall samþykktra tilboða...

Continue reading

Dom i sag anlagt af Clipper Group A/S

Med henvisning til selskabsmeddelelse nr. 10/2016 og nr. 16/2015 er der dags dato truffet afgørelse ved Københavns Byret i den af Clipper Group A/S anlagte sag mod PARKEN Sport & Entertainment A/S.Clipper Group A/S havde nedlagt påstand om betaling af kr. 82.978.800 med tillæg af renter fra sagens anlæg.Kravet knytter sig til handlinger foretaget af den tidligere ledelse af PARKEN Sport & Entertainment A/S, Flemming Østergaard og Jørgen Glistrup, i forbindelse med salg af aktier i PARKEN Sport & Entertainment A/S til Clipper Group A/S gennemført henholdsvis den 10. januar 2008 og 14. maj 2008.PARKEN Sport & Entertainment A/S blev af Københavns Byret dømt til betaling af kr. 3.750.000 til Clipper Group A/S med tillæg af renter fra sagens anlæg. Hver part skal betale egne sagsomkostninger.PARKEN Sport & Entertainment...

Continue reading

Boliga Gruppen A/S: Indberetning af ledende medarbejderes transaktioner med aktier i Boliga Gruppen A/S

Boliga Gruppen A/SCVR.nr. 25078780(“Selskabet“)Fondsbørsmeddelelse nr. 11/2020Boliga Gruppen A/S har modtaget oplysninger om følgende transaktioner med selskabets aktie foretaget af ledende medarbejdere.Første indberetningFor yderligere information, kontakt venligst:Boliga Gruppen A/SLaust Farver, CEOTelefon: +45 28 40 49 88Mail: lf@boligagruppen.dk

Continue reading

Laurentian Bank Financial Group declares dividends on its common shares

MONTREAL, Sept. 04, 2020 (GLOBE NEWSWIRE) — At its meeting held on September 3, 2020, the Board of Directors of the Laurentian Bank of Canada (TSX: LB) (the “Bank”) declared a regular quarterly dividend of 40 cents per share on the common shares payable on November 1, 2020 to the holders of record at the close of business on October 1, 2020.The above-mentioned dividends are designated as eligible dividends for the purposes of the Income Tax Act (Canada) and any similar provincial and territorial legislation.The above-mentioned shares are eligible shares under the Bank’s Shareholder Dividend Reinvestment and Share Purchase Plan (the “Plan”). Consequently, the holders of such shares may elect to reinvest their dividends in newly issued common shares of the Bank. Such purchases will be made at the applicable investment price as defined...

Continue reading

Banque Laurentienne Groupe Financier déclare des dividendes sur ses actions ordinaires

MONTRÉAL, 04 sept. 2020 (GLOBE NEWSWIRE) — Lors de sa réunion du 3 septembre 2020, le conseil d’administration de la Banque Laurentienne du Canada (TSX : LB) (la « Banque ») a déclaré un dividende trimestriel régulier de 40 cents par action sur les actions ordinaires payable le 1er novembre 2020 aux actionnaires inscrits à la fermeture des affaires le 1er octobre 2020.Les dividendes mentionnés ci-dessus sont considérés comme des dividendes admissibles aux fins de la Loi de l’impôt sur le revenu (Canada) et de toute loi provinciale ou territoriale similaire.Les actions ci-haut mentionnées sont des actions admissibles au régime de réinvestissement de dividendes et d’achat d’actions de la Banque (le « Régime »). Par conséquent, les détenteurs de ces actions peuvent choisir de réinvestir leurs dividendes sous forme d’actions ordinaires...

Continue reading

Crinetics Pharmaceuticals Provides New Data from Paltusotine and ACTH Antagonist Development Programs at European Congress of Endocrinology

SAN DIEGO, Sept. 04, 2020 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, today announced that a presentation on the company’s orally administered, small molecule adrenocorticotropic hormone (ACTH) antagonist was selected for a late-breaking session at the virtual European Congress of Endocrinology (eECE) on September 8, 2020. In addition, a poster summarizing results from Phase 1 bioavailability studies of paltusotine (formerly CRN00808), the company’s lead candidate for the treatment of acromegaly, will be available to congress attendees from September 5-9, 2020.Crinetics is developing an ACTH antagonist for the treatment of diseases...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.